Global Nucleic Acid Nanotechnology 麻豆原创 Research Report 2024

Publication ID:

PB511246704

Publication Date:

November 13, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global Nucleic Acid Nanotechnology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Nucleic Acid Nanotechnology is a technology that uses nucleic acids (such as DNA and RNA) as basic building blocks or templates to design, build and manipulate nanoscale structures and systems. This technology combines the characteristics of biomolecular self-assembly with the application of nanotechnology. Nucleic acid nanotechnology has a wide range of applications in many fields, including drug delivery, gene therapy, biosensors, vaccine development and nanorobots. With the continuous deepening of research, nucleic acid nanotechnology is expected to play an increasingly important role in fields such as biomedicine, materials science and synthetic biology.
North American market for Nucleic Acid Nanotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nucleic Acid Nanotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Nucleic Acid Nanotechnology in Drug Delivery Systems is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Nucleic Acid Nanotechnology include GATTAQUANT GMBH, NuProbe, Genisphere, Nanovery, Esya Labs, Nomic,, Torus Biosystems, NanoApps Medical, Inc., Creative Biolabs, tilibit nanosystems, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Nanotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Nanotechnology.
The Nucleic Acid Nanotechnology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Nanotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Nanotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
GATTAQUANT GMBH
NuProbe
Genisphere
Nanovery
Esya Labs
Nomic,
Torus Biosystems
NanoApps Medical, Inc.
Creative Biolabs
tilibit nanosystems
Segment by Type
DNA Nanotechnology
RNA Nanotechnology
Segment by Application
Drug Delivery Systems
Biosensors
Nanorobotics
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Nanotechnology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Nucleic Acid Nanotechnology 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA Nanotechnology
1.2.3 RNA Nanotechnology
1.3 麻豆原创 by Application
1.3.1 Global Nucleic Acid Nanotechnology 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Delivery Systems
1.3.3 Biosensors
1.3.4 Nanorobotics
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Nanotechnology 麻豆原创 Perspective (2019-2030)
2.2 Global Nucleic Acid Nanotechnology Growth Trends by Region
2.2.1 Global Nucleic Acid Nanotechnology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nucleic Acid Nanotechnology Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Nucleic Acid Nanotechnology Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Nucleic Acid Nanotechnology 麻豆原创 Dynamics
2.3.1 Nucleic Acid Nanotechnology Industry Trends
2.3.2 Nucleic Acid Nanotechnology 麻豆原创 Drivers
2.3.3 Nucleic Acid Nanotechnology 麻豆原创 Challenges
2.3.4 Nucleic Acid Nanotechnology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Nanotechnology Players by Revenue
3.1.1 Global Top Nucleic Acid Nanotechnology Players by Revenue (2019-2024)
3.1.2 Global Nucleic Acid Nanotechnology Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Nucleic Acid Nanotechnology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nucleic Acid Nanotechnology Revenue
3.4 Global Nucleic Acid Nanotechnology 麻豆原创 Concentration Ratio
3.4.1 Global Nucleic Acid Nanotechnology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Nanotechnology Revenue in 2023
3.5 Global Key Players of Nucleic Acid Nanotechnology Head office and Area Served
3.6 Global Key Players of Nucleic Acid Nanotechnology, Product and Application
3.7 Global Key Players of Nucleic Acid Nanotechnology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Nanotechnology Breakdown Data by Type
4.1 Global Nucleic Acid Nanotechnology Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Nucleic Acid Nanotechnology Forecasted 麻豆原创 Size by Type (2025-2030)
5 Nucleic Acid Nanotechnology Breakdown Data by Application
5.1 Global Nucleic Acid Nanotechnology Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Nucleic Acid Nanotechnology Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid Nanotechnology 麻豆原创 Size (2019-2030)
6.2 North America Nucleic Acid Nanotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nucleic Acid Nanotechnology 麻豆原创 Size by Country (2019-2024)
6.4 North America Nucleic Acid Nanotechnology 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Nanotechnology 麻豆原创 Size (2019-2030)
7.2 Europe Nucleic Acid Nanotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nucleic Acid Nanotechnology 麻豆原创 Size by Country (2019-2024)
7.4 Europe Nucleic Acid Nanotechnology 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Nanotechnology 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Nucleic Acid Nanotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nucleic Acid Nanotechnology 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Nucleic Acid Nanotechnology 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Nanotechnology 麻豆原创 Size (2019-2030)
9.2 Latin America Nucleic Acid Nanotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nucleic Acid Nanotechnology 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Nucleic Acid Nanotechnology 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Nanotechnology 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Nucleic Acid Nanotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nucleic Acid Nanotechnology 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Nucleic Acid Nanotechnology 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GATTAQUANT GMBH
11.1.1 GATTAQUANT GMBH Company Details
11.1.2 GATTAQUANT GMBH Business Overview
11.1.3 GATTAQUANT GMBH Nucleic Acid Nanotechnology Introduction
11.1.4 GATTAQUANT GMBH Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.1.5 GATTAQUANT GMBH Recent Development
11.2 NuProbe
11.2.1 NuProbe Company Details
11.2.2 NuProbe Business Overview
11.2.3 NuProbe Nucleic Acid Nanotechnology Introduction
11.2.4 NuProbe Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.2.5 NuProbe Recent Development
11.3 Genisphere
11.3.1 Genisphere Company Details
11.3.2 Genisphere Business Overview
11.3.3 Genisphere Nucleic Acid Nanotechnology Introduction
11.3.4 Genisphere Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.3.5 Genisphere Recent Development
11.4 Nanovery
11.4.1 Nanovery Company Details
11.4.2 Nanovery Business Overview
11.4.3 Nanovery Nucleic Acid Nanotechnology Introduction
11.4.4 Nanovery Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.4.5 Nanovery Recent Development
11.5 Esya Labs
11.5.1 Esya Labs Company Details
11.5.2 Esya Labs Business Overview
11.5.3 Esya Labs Nucleic Acid Nanotechnology Introduction
11.5.4 Esya Labs Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.5.5 Esya Labs Recent Development
11.6 Nomic,
11.6.1 Nomic, Company Details
11.6.2 Nomic, Business Overview
11.6.3 Nomic, Nucleic Acid Nanotechnology Introduction
11.6.4 Nomic, Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.6.5 Nomic, Recent Development
11.7 Torus Biosystems
11.7.1 Torus Biosystems Company Details
11.7.2 Torus Biosystems Business Overview
11.7.3 Torus Biosystems Nucleic Acid Nanotechnology Introduction
11.7.4 Torus Biosystems Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.7.5 Torus Biosystems Recent Development
11.8 NanoApps Medical, Inc.
11.8.1 NanoApps Medical, Inc. Company Details
11.8.2 NanoApps Medical, Inc. Business Overview
11.8.3 NanoApps Medical, Inc. Nucleic Acid Nanotechnology Introduction
11.8.4 NanoApps Medical, Inc. Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.8.5 NanoApps Medical, Inc. Recent Development
11.9 Creative Biolabs
11.9.1 Creative Biolabs Company Details
11.9.2 Creative Biolabs Business Overview
11.9.3 Creative Biolabs Nucleic Acid Nanotechnology Introduction
11.9.4 Creative Biolabs Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.9.5 Creative Biolabs Recent Development
11.10 tilibit nanosystems
11.10.1 tilibit nanosystems Company Details
11.10.2 tilibit nanosystems Business Overview
11.10.3 tilibit nanosystems Nucleic Acid Nanotechnology Introduction
11.10.4 tilibit nanosystems Revenue in Nucleic Acid Nanotechnology Business (2019-2024)
11.10.5 tilibit nanosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

GATTAQUANT GMBH
NuProbe
Genisphere
Nanovery
Esya Labs
Nomic,
Torus Biosystems
NanoApps Medical, Inc.
Creative Biolabs
tilibit nanosystems

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.